Free Trial
→ Trump’s betrayal exposed (From Porter & Company) (Ad)

Will the Biotech sector sustain its momentum in 2024?

Ryan Hasson
Written by Ryan Hasson | Reviewed by Don Miller
January 4, 2024

Key Points

  • Biotech's iShares ETF (IBB) experienced a near 4% upswing on the year's first trading day, outshining struggling sectors.
  • The IBB ETF now faces critical resistance at $138 after a robust three-month climb.
  • AMGN, VRTX, and GILD, the top holdings in the ETF, significantly impact the sector's direction based on their individual performances.
  • MarketBeat previews the top five stocks to own by April 1st.
Remove Ads

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in iShares Biotechnology ETF Right Now?

Before you consider iShares Biotechnology ETF, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iShares Biotechnology ETF wasn't on the list.

While iShares Biotechnology ETF currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Ryan Hasson
About The Author

Ryan Hasson

Contributing Author

Technical Analysis, Momentum Trading, Risk Management

Learn More about Ryan Hasson
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Amgen (AMGN)
4.4641 of 5 stars		$305.77+0.0%3.11%40.50Hold$314.04
Gilead Sciences (GILD)
4.602 of 5 stars		$111.16+1.7%2.84%300.43Moderate Buy$105.12
Vertex Pharmaceuticals (VRTX)
3.8855 of 5 stars		$502.55+0.5%N/A-228.43Moderate Buy$506.70
iShares Biotechnology ETF (IBB)N/A$131.58+0.3%0.29%27.83Moderate Buy$131.58
Compare These Stocks  Add These Stocks to My Watchlist 

Remove Ads

Featured Articles and Offers

Quantum Stocks Are Heating Up Again — 7 to Watch Now

Quantum Stocks Are Heating Up Again — 7 to Watch Now

After a brief dip earlier this year, fresh momentum has reignited interest; from penny plays to tech giants, these quantum stocks could lead the next surge.

Related Videos

Quantum Stocks Are Heating Up Again — 7 to Watch Now
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads